Cargando…
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
Autores principales: | Liu, Nan, Zhou, Lifang, Lin, Guifeng, Hu, Yun, Jiao, Yaoge, Wang, Yanhong, Liu, Jingming, Yang, Shengyong, Yao, Shaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547179/ https://www.ncbi.nlm.nih.gov/pubmed/36250209 http://dx.doi.org/10.1016/j.omtn.2022.09.021 |
Ejemplares similares
-
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022) -
Bi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells
por: Tao, Rui, et al.
Publicado: (2022) -
WT-PE: Prime editing with nuclease wild-type Cas9 enables versatile large-scale genome editing
por: Tao, Rui, et al.
Publicado: (2022) -
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020) -
CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)